Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
medical device mergers & acquisitions
MedTech
Medtech M&A 'rebounded' in 2025: report
Bain & Company found that medtech deals rebounded last year, with M&A players in 2026 seeking to “outperform the next-best owner.”
Ben Adams
Jan 28, 2026 7:55am
Boston Scientific to snap up Penumbra in deal valued at $14.5B
Jan 15, 2026 8:12am
JPM: Medtronic to 'step up' in M&A, exec says
Jan 13, 2026 8:50am
Haemonetics to pay up to €185M to acquire device maker Vivasure
Jan 12, 2026 9:55am
Staar Surgical's takeover saga ends as Alcon terminates deal
Jan 7, 2026 8:00am
Philips augments cardiac AI programs with Cardiologs acquisition
Nov 8, 2021 10:50am
